SCHEMBL2575833

SCHEMBL2575833

NC(=O)N(S)c1cccc(C(F)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.47
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
CETP P11597 1/20 0.43
KIF11 P52732 2/20 0.43
ALDH1A1 P00352 3/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
EPHX1 P07099 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
TP53 P04637 1/20 0.42
SRD5A2 P31213 1/20 0.41
MEN1 O00255 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606524 0.83 CES2 (0.50) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL966453 0.81 CES2 (0.49) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL27946915 0.80 CES2 (0.47) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL525760 0.79 CES2 (0.45) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL28217598 0.79 PTGIR (0.46) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL11578705 0.78 CES2 (0.45) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL9264543 0.77 PARP1 (0.48) CES2ALDH1A1EPHX1PKMMEN1
SCHEMBL3389830 0.76 HTR3E (0.46) CES2HTR3EHTR3BHTR3AHTR3D
SCHEMBL7739130 0.75 CES2 (0.50) CES2ALDH1A1MAPTLMNASRD5A2
SCHEMBL7738559 0.74 SRD5A2 (0.52) CES2ALDH1A1LMNASRD5A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283023-A1 Dual-Curing Dental Compositions with High Stability JAMES R. GLIDEWELL DENTAL CERAMICS, INC. 2021-09-16 US disclosed
US-11020324-B2 Dual-curing dental compositions with high stability JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) 2021-06-01 US disclosed
US-20200268615-A1 Dual-Curing Dental Compositions with High Stability JAMES R. GLIDEWELL DENTAL CERAMICS, INC. 2020-08-27 US disclosed
EP-1926719-B1 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-05-31 EP disclosed
US-9388175-B2 2-aniline-4-aryl substituted thiazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2016-07-12 US disclosed
US-20110269748-A1 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2011-11-03 US disclosed
EP-1926719-A2 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2008-06-04 EP disclosed
WO-2007031440-A2 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269748-A1 2-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES CHRNA4, CHRNA5, CHRNA7 CES2 1240/4885HTR3E 62/4885HTR3B 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.